
Novamind (OTC: NVMDF) Increases Strategic Investment in Bionomics
Investment supports phase IIb clinical trial examining novel PTSD treatment TORONTO, ON / April 13, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is pleased to […]